Posted on 11/24/20
Better Buy: Gilead Sciences vs. Pfizer
Two healthcare giants have been at the forefront in the fight against COVID-19. Gilead Sciences (NASDAQ:GILD) was among the first companies to win FDA emergency use . . .
Posted on 11/24/20
Select Medical Holdings Corp.: Breakout Underway
SummarySince its earnings report, it has broken out from the healthcare sector in the broad market.Trading above its 50- and 200-day averages.Issued guidance that full-year results . . .
Posted on 11/24/20
Advaxis Announces Proposed Public Offering of Common Stock
PRINCETON, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today . . .
Posted on 11/23/20
Baudax Bio Offers $12 Million Common Stock
MALVERN, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that it . . .
Posted on 11/23/20
Merck To Acquire OncoImmune For $425M
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and OncoImmune, a privately-held, clinical-stage biopharmaceutical company
Posted on 11/23/20
Here's Why Moderna's Coronavirus Vaccine Could Outsell Pfizer's
If you could get a coronavirus inoculation this afternoon, you probably wouldn't care if the clinician told you that the shot might feel a bit chilly. . . .
Posted on 11/23/20
How Do Pfizer's and Moderna's COVID Vaccine Results Compare?
We've now heard interim results for two of the leading coronavirus vaccine candidates. Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) announced initial data for their experimental COVID-19 vaccine BNT162b2 on . . .
Posted on 11/23/20
Is Pfizer Stock A Good Bet On Coronavirus Vaccines?
Pfizer (NYSE:PFE) and its German partner BioNTech (NASDAQ:BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired . . .
Posted on 11/23/20
Is Pfizer and BioNTech's Potential mRNA Coronavirus Vaccine Revolutionary?
Pfizer (NYSE:PFE) and its German partner BioNTech (NASDAQ:BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired . . .
Posted on 11/23/20
Is Inovio Back in the Coronavirus Vaccine Race?
Inovio Pharmaceuticals (NASDAQ:INO) investors can breathe a little easier this week after the U.S. Food and Drug Administration lifted a partial clinical hold on the planned . . .
Posted on 11/23/20
Matinas BioPharma Awarded up to $3.75M from the Cystic Fibrosis Foundation
BEDMINSTER, N.J., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to . . .
Posted on 11/20/20
Is Pfizer a Smart Coronavirus Stock to Buy After Moderna's Great Vaccine Results?
The euphoria surrounding last week's news about tremendous efficacy results for the experimental coronavirus vaccine developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) didn't last long. On . . .
Posted on 11/20/20
Inovio: Accumulate For The HPV And Brain Cancer Therapies
SummaryFirst commercial approvals could be for HPV therapies in 2022.Brain cancer (glioblastoma) data could indicate a multibillion-dollar opportunity.COVID-19 vaccine success could still be in time for . . .
Posted on 11/20/20
For Fourth Year in a Row, Geneia Named a Best Places to Work in PA
Geneia, a healthcare analytic solutions and services company that is simplifying the transition to value-based care, proudly announces it has been named one of the Best . . .
Posted on 11/19/20
The Motley Fool Sits Down With A Doctor About Pfizer's Coronavirus Vaccine News
Pfizer (NYSE:PFE) and its German partner BioNTech (NASDAQ:BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate last Monday. While . . .
Posted on 11/19/20
1 Reason Why Moderna's Coronavirus Vaccine Candidate Just Took the Lead Away from Pfizer
Key Points Pfizer's vaccine candidate showed it was more than 95% effective, while Moderna's efficacy was 94.5%.Both companies continue to collect trial data, so figures may . . .
Posted on 11/19/20
Moderna's and Pfizer's Vaccine News May Signal a Market Top
This has been a huge month for news, and Wall Street and has been taking in every drop of it. On election night, we learned that . . .
Posted on 11/18/20
MedAvail Combines with MYOS RENS
MISSISSAUGA, Ontario & CEDAR KNOLLS, N.J.--(BUSINESS WIRE)--MedAvail, Inc., a leading technology-enabled pharmacy organization that embeds pharmacy services directly into clinics and other points of care through . . .
Posted on 11/18/20
Pfizer Launching Coronavirus Immunization Pilot Program in the U.S.
Pfizer (NYSE:PFE) announced late Monday that it has launched an Immunization Pilot Program in four U.S. states -- Texas, Rhode Island, New Mexico, and Tennessee.This is . . .
Posted on 11/18/20
Pfizer May File for Emergency Authorization of Coronavirus Vaccine Within the Week
Pfizer (NYSE:PFE) may be about to take a major step forward in its coronavirus vaccine development efforts."We are very close to submitting for an emergency use . . .
Posted on 11/18/20
Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?
As the world watches the race for an effective and safe coronavirus vaccine, one company that was leading the charge early in the pandemic has experienced . . .
Posted on 11/18/20
Virion Therapeutics Wins Prestigious 'Most Valued Company' at Keiretsu Forum Investor Capital Expo
Virion Therapeutics, developing novel T cell based treatments for cancers and infectious diseases using the world's first genetically encoded checkpoint inhibitor, was one of three companies . . .
Posted on 11/17/20
Beverage Companies Urge Marylanders to Keep Recycling Especially During the Pandemic
The COVID-19 pandemic has brought about drastic changes to our daily lives. The share of products consumed, used and disposed of at home has grown – . . .
Posted on 11/16/20
Pfizer Combine Its Upjohn Business with Mylan
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. . . .
Posted on 11/16/20
Legend Biotech Reports Third Quarter 2020 Financial Results
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other . . .
Philadelphia
